Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateUploadPipelinePE CyclesBrainAbout

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Deep Value
  3. /Lab Grown Diamonds
MomentumDeep Value

Which Lab Grown Diamonds Stocks Are Deep Value Picks in Week of May 31, 2026?

In the Week of May 31, 2026, the Lab Grown Diamonds sector has 1 stocks that are underperforming Nifty 500 but have accelerating quarterly earnings. Average value score is 35/100.

Total Stocks
1
deep value
Avg Fundamental
35
/100
Top Pick
Renaissance
Score: 35/100
Avg Margin of Safety
—

Stock Distribution

0 Strong0 Good0 Average1 Weak

AI Research Summary

Sector Pulse

The Lab Grown Diamond (LGD) sector is exhibiting 18-21% revenue growth across both manufacturing and certification segments. GOLDIAM reported 18% revenue growth driven by U.S. demand, while IGIL saw 21% growth supported by an 11% volume increase. The demand environment is characterized as 'STRONG' by management, with IGIL noting that retail showrooms for LGD have surpassed 1,000 in India, signaling rapid domestic adoption alongside established export markets.

Catalysts Playing Out Across the Pack

Operating leverage is the primary driver of profitability. IGIL reported a 59.9% EBITDA margin, noting that the 'business model provides great operating leverage as revenue scales.' GOLDIAM similarly saw margins reach 26.7%, significantly above its 18-22% guidance, attributed to its 'U.S. origin casting model' which allowed it to pass on costs. Additionally, the shift toward value-added products is evident; GOLDIAM's LGD jewelry exports reached 90.5% of its mix, up from 80% YoY, while IGIL reported 35% growth in LGD loose stone certifications.

What Managements Are Guiding

Managements are projecting continued growth for the remainder of the fiscal year. GOLDIAM is 'expecting to deliver a record financial year' and raised its store count target to 24-26 by March 2026. IGIL reaffirmed its outlook, citing industry expectations to 'double lab-grown diamond caratage over the next three years,' providing a long-term growth runway. Both companies are well-capitalized, with aggregate cash reserves exceeding ₹1,300 crores.

Sub-Sector Aggregates

The sector maintains high profitability, with an EBITDA margin range of 26.7% to 59.9%. Revenue growth remains consistent between 18% and 21% YoY. Liquidity is a major strength, with aggregate cash and investments across the two analyzed constituents totaling approximately ₹1,364 crores (₹504 Cr for GOLDIAM and ₹860 Cr for IGIL). LGD-specific growth remains the primary driver, with IGIL seeing 35% growth in loose stone volumes.

Shared Risks (9-type taxonomy)

Regulatory risk remains the primary concern due to U.S. tariffs. GOLDIAM noted tariffs were raised to a 'steep 56%' before being adjusted, while IGIL is monitoring 'dynamic changes' in trade policy. Commodity risk is also active, with both firms citing 'steep increases in prices of gold' as a factor impacting inventory value and demand dynamics. GOLDIAM also highlighted FX risk, noting that dollar-rupee depreciation impacts other income.

Bottom Line

The sector is benefiting from a structural shift in consumer preference toward LGD, leading to high operating leverage and margin beats. While regulatory uncertainty regarding U.S. tariffs persists, constituents are successfully navigating these through supply chain adjustments and geographical diversification into Europe and the Middle East.

Last updated Apr 19, 2026

1 stocks in this sector

View:
Weak35/100

Renaissance Global Ltd

1.1K Cr
Fairly Valued
Earnings Pulse
PAT YoY
—
Revenue YoY
—
Momentum
—

Explore More

All Deep Value SectorsMomentum Sectors← Back to Dashboard

Frequently Asked Questions: Lab Grown Diamonds

Based on publicly available financial data. This is educational research, not investment advice.

How many Lab Grown Diamonds stocks are deep value opportunities worth studying?

There are currently 1 stocks in the Lab Grown Diamonds sector that qualify as deep value opportunities worth studying. These stocks are underperforming the market despite showing improving earnings — a classic contrarian research signal.

Why are Lab Grown Diamonds stocks underperforming despite improving earnings?

Lab Grown Diamonds deep value stocks are underperforming despite improving earnings because the market has not yet recognized their earnings recovery. This creates a potential opportunity for patient investors

  • The market often takes 2-4 quarters to re-rate stocks after earnings improve
  • Deep value stocks typically have a negative narrative that suppresses sentiment
  • Improving earnings combined with market underperformance creates a valuation gap
  • When the market eventually recognizes the recovery, re-rating can be significant
  • This is an educational explanation of deep value investing theory.

Is the earnings recovery in Lab Grown Diamonds sustainable?

Sustainability indicators for the Lab Grown Diamonds deep value earnings recovery

  • A sustainable recovery shows more stocks accelerating than decelerating.

Is Lab Grown Diamonds a contrarian opportunity worth studying?

Lab Grown Diamonds as a contrarian opportunity — key research signals

  • 1 stocks underperforming the market (contrarian setup)
  • Contrarian investing requires patience.

What is the typical recovery timeline for deep value stocks?

Deep value stock recovery timelines vary, but historical patterns suggest

  • 1-2 quarters: Earnings inflection detected, market still skeptical
  • 2-4 quarters: Consistent earnings improvement builds confidence
  • 4-6 quarters: Market re-rates, stock price catches up to fundamentals
  • Some stocks never recover — continuous monitoring is essential
  • Timelines are approximate and based on historical patterns.

What is deep value investing?

Deep value investing is a strategy of studying stocks that are underperforming the market despite showing improving fundamentals (earnings growth, margin expansion). The thesis is that the market has not yet recognized the earnings recovery, creating a potential valuation gap.

  • These stocks typically underperform indices like Nifty 500
  • They show positive earnings trends (PAT growth, revenue growth)
  • The market eventually re-rates them as earnings improvements sustain
  • It requires patience — recovery can take several quarters

The above FAQs are based on publicly available financial data. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.